Biggest S&P 500 Movers and Market Updates for Monday

Biggest S&P 500 Movers on Monday

34 minutes ago

Decliners

• Moderna (MRNA) lost the most ground in the S&P 500, plummeting 7.3%. This decline continued from last week’s losses after Goldman Sachs downgraded the stock to “neutral.” Goldman cited Moderna’s repeated revenue cuts and elevated operating expenses, projecting it won’t break even cash-wise until 2029.
• FedEx (FDX) also faced a rough day, dropping 6.6%. Loop Capital downgraded the company to “hold” and lowered its price target, citing the White House’s tariff announcement and potential pressure on transportation volumes.
• Tesla (TSLA) tumbled 5.2%. Investors worried about the implications of Trump’s tariffs on the global trade environment, especially given Tesla’s significant presence in China and its brand image in European markets.

• Franklin Resources (BEN) shares fell 6.9% despite posting better-than-expected profits. Analysts attributed the slide to missed revenue targets and decreasing assets under management, which reflected higher net outflows.

Advancers

• IDEXX Laboratories (IDXX) soared 11.1% following better-than-expected fourth-quarter sales and profits. Growing demand for the company’s animal healthcare solutions drove this strong performance.
• Molina Healthcare (MOH) gained 4.8%. Ahead of its earnings report, analysts predict a significant growth in sales and profits, partly attributed to its focus on low-income populations.
• AbbVie (ABBV) saw its stock rise 3.4%. Analysts raised price targets following strong fourth-quarter earnings from its anti-inflammatory drugs, Skyrizi, and Rinvoq, with AbbVie revising its long-term sales outlook for these treatments.

–Michael Bromberg

Palantir Sails High on Bullish AI Outlook

1 hr 19 min ago

Palantir’s (PLTR) share price soared in extended trading Monday after the company reported strong fourth-quarter results and upbeat forecasts for 2025.

The analytics software provider’s revenue climbed 36% year-over-year to $828 million, surpassing market expectations due to robust demand for its AI Platform.

“Our business results continue to astound, demonstrating our deepening position at the center of the AI revolution,” Palantir CEO Alex Karp stated.

Palantir forecasted 2025 revenue of $3.74 billion to $3.76 billion, exceeding analyst projections of $3.51 billion. Shares climbed more than 20% in extended trading, hitting a record high of $83.74.

In just 12 months, Palantir’s stock has quintupled in value.

–Andrew Kessel

Tesla Slips as Tariffs Cast Doubt

2 hr 2 min ago

Tesla (TSLA) led the downturn among the Magnificent Seven stocks, dropping over 5%. The slide followed President Trump’s move to impose tariffs on major trading partners, including Mexico and Canada, where Tesla sources some components.

Corporate tensions escalated further with Canadian officials discussing potential retaliatory actions against U.S. tech leaders like Elon Musk.

–Colin Laidley

Nvidia’s Slide Continues Amidst Global Trade Concerns

2 hr 59 min ago